The Meeting Summary provides brief descriptions of selected actions taken by the NC Medical Board during its most recent meeting or hearing. Actions are listed by committee, where applicable.
For a full account of the Board’s proceedings please check the meeting minutes, which are posted approximately two months after the meeting date. You can subscribe to our Meeting Minutes RSS feed to be notified when the minutes are posted.
Summary of the Board Meeting held May 17-18, 2017
Advanced Practice Providers and Allied Health
The Board voted to submit the name of Summit Bhanji Kundaria, MD, to Governor Cooper for appointment to the NC Board of Electrolysis Examiners.
In January 2017, the Board approved for publication and comment proposed changes to Rule 21 NCAC 32Y .0101, also known as the Safe Opioid Prescribing Initiative (“SOPI”), reporting criteria. SOPI identifies prescribers for investigation based on criteria established by the Board, using data from the NC Controlled Substances Reporting System. The Executive Committee carefully considered all comments received regarding the proposed changes, including suggestions to exempt hospice providers and to modify the reporting threshold for atypical opioids.
The Board voted to approve the proposed rule changes without modification. If finally approved by the NC Rules Review Commission, the new criteria would be:
Revised SOPI investigative criteria:
• Top two percent prescribing 100 morphine milligram equivalents (MME) per patient per day.
• Top two percent prescribing 100 MMEs per patient per day in combination with any benzodiazepine and within the top one percent of all controlled substance prescribers by volume.
• Prescribers with two or more patient deaths within a 12–month period due to opioid poisoning AND authorized 30+ tablets of an opioid to the decedent AND scripts were written within 60 days of the patient’s death.
The Committee received an update on the collaboration between NCMB and Wake AHEC, which resulted in a free webinar that discusses the CDC Guideline for Prescribing Opioids for Chronic Pain and four live opioid panel discussions held in the greater Triangle. Licensees who completed the webinar and attended one panel discussion earned a total of three hours of AMA PRA Category 1 CME – enough to satisfy the new CME requirement for controlled substances prescribers that will be in effect July 1. The Committee was informed that NCMB and Wake AHEC received approval for additional grant funding to support up to 20 additional panel discussions across North Carolina. The first of these additional sessions will be held in September.
Position statement review – The Committee discussed the position statement entitled Medical Record Documentation. The issue of electronic health records and whether more expansive guidance is warranted was discussed. The committee agreed that the position statement should be revised to include a clear statement of the Board’s expectations regarding documentation in electronic medical records. The Board asked staff to draft language for consideration by the Committee at the July 2017 Board meeting.
Position statement review – The Committee discussed that the Board’s position statement entitled Medical Record Documentation. The current position reflects the expectations of other entities regarding retention of records, but it might be helpful for the Board to articulate its own expectations to the Board’s licensees. The Committee instructed staff to draft a position statement for consideration at the July 2017 Board meeting.
Position statement review - The committee discussed the current relevance of the position statement entitled Treatment of Obesity and whether it should be modified or deleted. After a consensus that the position statement is still relevant, it was suggested that in addition to mentioning hCG, the position statement should also include language addressing the inappropriate use of phentermine. The Committee instructed staff to prepare draft revisions for consideration at the July 2017 Board meeting.